AI assistant
AGENUS INC — Director's Dealing 2015
Sep 18, 2015
34023_dirs_2015-09-18_007aed07-c112-4cd2-b779-f891714090bc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2015-09-16
Reporting Person: ARMEN GARO H (Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-16 | Common Stock | J | 83697 | $6.61 | Acquired | 1393304 | Direct |
| 2015-09-16 | Common Stock | J | 60500 | $6.50 | Disposed | 1332804 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 220349 | Indirect |
Footnotes
F1: Represents required distribution from the Garo Armen 2014 2 year GRAT.
F2: Represents shares donated to a charitable organizations.
F3: Dr. Armen is trustee and has investment authority for the Garo Armen 2014 2 Year GRAT holding 216,303 shares of Agenus Inc. common stock. Dr. Armen disclaims beneficial ownership. Dr. Armen is also Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.